August was the month of pain.
In August, per HFR, the average fund lost 2.2% (versus the S&P 500’s 6% fall) and is down 1% for the year. Some big name factivists aren’t so lucky.
Bill Ackman’s Pershing Square was down 9.2% in August, putting the fund down 0.1% for the year.
Themes for the next decade: Cannabis, 5G, and EVs
A lot changes in 10 years, and many changes are expected by the time 2030 rolls around. Some key themes have already emerged, and we expect them to continue to impact investing decisions. At the recent Morningstar conference, several panelists joined a discussion about several major themes for the next decade, including cannabis, 5G and Read More
Top holding Mondelez (MDLZ) was down 6% for the month of August, no. 2 holding Valeant (VRX) was off 10.5%, no. 3 Air Products was down 2%, no. 4 Canadian Pacific (CP) was down 10%, no. 5 Zoetis (ZTS) down 8% and no. 5 Restaurant Brands (QSR) off 11%. Collectively, eight make up the bulk of the long-only portfolio.
David Einhorn’s Greenlight Capital was down 5.3% in August and now down 13.8% for the year.
Top holdings Apple (AAPL) and GM (GM) were down 7% and 6.6%, respectively, in August. Everyone wants to talk about SunEdison, which was off 55% for the month, with Micron Tech and CONSOL also being down 11% and 8%, respectively, for the month. Einhorn was cutting some of his long and short bets in August, though.
Dan Loeb’s Third Point was off 5.2% last month, but still up 1.2% for the year.
Third Point’s top holding, Baxter (BAX) was off 4% in August, no. 2 holding Amgen (AMGN) was down 14% and no. 3 Allergan (AGN) was down 8.2%. Collectively, the three make up about 40% of the long-only portfolio.
Barry Rosenstein’s JANA Partners was down 4.3% in August and down 2.9% for the year.
JANA’s top holding, Qualcomm (QCOM), was down 12% in August. Other top holdings off big in August were Walgreen (WBA), down 10.4%, and ConAgra (CAG), down 5.4%.
Other activists down in August were Cliff Robbins’ Blue Harbour, off 2.6% for the month, and Scott Ferguson’s Sachem Head Capital, down 2%.
Jeff Ubben’s ValueAct Capital, up 1.6% in 2Q, the standout of sorts – although it remains to be seen how he did in August. YTD through June, ValueAct is up 8%.
By all accounts, it wasn’t a pretty August for ValueAct either, however. Top holding Valeant was down 10.5% in August, no. 2 holding Microsoft (MSFT) took a 7% hit during the month, no. 3 Halliburton (HAL) was off 6%, no. 4 Fox (FOX) off 17.5%, no. 5 Adobe (ADBE) down 4%. Collectively, the top 5 holdings make up 60% to 65% of its long-only portfolio.
That’ll be 2 and 20.
Don’t forget – sign up for our free daily newsletter to stay in the activist investing know.